Robert Schnoll, PhD
Associate Professor, Medicine/Psychiatry
Public Health Interests
Current Public-Health Related Activities
Dr. Schnoll is an Associate Professor in the Department of Psychiatry, co-leader of the Tobacco and Environmental Carcinogenesis Program at the Abramson Cancer Center, Senior Fellow at the Center for Public Health Initiatives, and Program Leader for the Center for Interdiscplinary Research on Nicotine Addiction at the University of Pennsylvania. Dr. Schnoll directs an independent and collaborative research program designed to evaluate methods for improving treatments for tobacco dependence. After receiving his Ph.D. in psychology from the University of Rhode Island in 1998, Dr. Schnoll completed a post-doctoral fellowship in Cancer Prevention and Control at Fox Chase Cancer Center and remained there as a faculty member in the Division of Population Science until September, 2005, when he moved to his current position at the University of Pennsylvania. Dr. Schnoll’s research focuses on the study of new methods for treating tobacco dependence, the examination of novel ways to use existing treatments for tobacco dependence to improve their efficacy, and the study methods to improve the use of approved treatments for nicotine dependence. Dr. Schnoll has conducted behavioral, physician-based, and pharmacological clinical trials for smoking cessation and tobacco control research in developing countries. Dr. Schnoll has published over 95 peer-reviewed papers, received 13 NIH grants as PI, and has served on numerous NIH grant review and advisory committees.
Peng, A.R., Morales, M., Wileyto, E.P., Hawk, L.W., Cinciripini, P., George, T.P., Benowitz, N.L., Nollen, N.L., Lerman, C., Tyndale, R.F., Schnoll, R. (2017). Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addictive Behaviors, 75, 122-129.
Harrison, J.D., Dochney, J., Blazekovic, S., Leone, F., Metzger, D., Frank, I., Gross, R., Hole, A., Mounzer, K., Siegel, S., Schnoll, R.A., & Ashare, R. (2017). The nature and consequences of cognitive deficits among tobacco smokers with HIV: A comparison to tobacco smokers without HIV. Journal of NeuroVirology, 23, 550-557.
Price, S., Hitsman, B., Veluz-Wilkins, A., Blazekovic, S., Leone, F., Hole, A., Wileyto, E.P., Langer, C., Kalhan, R., Patel, J., Schnoll, R. (2017). The use of varenicline to treat nicotine dependence among cancer patients. Psycho-oncology, 26, 1526-1534.
Lerman, C., Schnoll, R.A., Hawk, L.W., Cinciripini, P., George, T.P., Wileyto, E.P., Swan, G.E., Benowitz, N.I., Heitjan, D.F., Tyndale, R.F., & the PGRN-PNAT Research Group. (2015). A randomized placebo-controlled trial to test a genetically-informed biomarker for personalizing treatment for tobacco dependence. Lancet Respiratory Medicine, 3, 131-138.